Skip to main content

Government Affairs, Health Policy, and Advocacy News

Government Affairs at Children's Hospital of Philadelphia works to identify and address problems impacting children that need legislative solutions and government action. 

Children’s Hospital of Philadelphia Researchers Find Extreme Heat Can Impact Youth Mental Health, Contributing to Aggression in Pre- and Early Adolescents

A new study from researchers at Children’s Hospital of Philadelphia (CHOP) found racial and ethnic disparities in pre- and early adolescent exposure to extreme heat, as well as a small but significant association between extreme heat and specific behavioral symptoms like aggression. The study was recently published in the journal JAACAP Open, the open-access journal of the American Academy of Child and Adolescent Psychiatry.

Children’s Hospital of Philadelphia Researchers Find White Children from Wealthier Socioeconomic Regions are More Likely to be Prescribed Opioids

Researchers in the Orthopedic Center at Children’s Hospital of Philadelphia (CHOP) found that white youth from wealthier socioeconomic areas were more likely to be prescribed opioids in the emergency room for supracondylar humerus (SCH) fractures, a broken elbow, compared with their same-age, non-white, peers from disadvantaged regions. The authors will present their abstract at the 2024 American Academy of Pediatrics (AAP) National Conference & Exhibition in Orlando, Florida.

How to Soothe a Baby with Colic

Sep 27, 2024

Babies with colic can cry for hours. A CHOP pediatrician offers suggestions for soothing a baby with colic, and for keeping yourself calm.

Researchers at Children’s Hospital of Philadelphia Reveal New Insights into Non-Inflammatory Causes of Rare Neurological Symptoms in Children, Adolescents and Young Adults Following CAR-T Therapy

Sep 26, 2024

Researchers at Children’s Hospital of Philadelphia (CHOP) revealed for the first time that children, adolescents and young adults may experience very rare neurological issues of paraparesis and quadriparesis following chimeric antigen receptor T-cell (CAR-T) therapy, a type of immunotherapy used to treat B-cell Acute Lymphoblastic Leukemia (B-ALL). Additionally, these complications occurred without the type of inflammation typically seen in adults. The findings were published today in the journal Blood.

Jump back to top